Illumina Aktie

123,23USD 2,38USD 1,97%
Illumina für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 927079 / ISIN: US4523271090

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 9 800 11 500 12 010 10 370 8 600
Umsatz pro Mitarbeiter in Mio. EUR 0,46 0,40 0,38 0,42 0,50

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 2 713 3 561 2 609 2 746 3 289
Summe Anlagevermögen 12 504 8 691 7 502 3 557 3 355
Summe Aktiva 15 217 12 252 10 111 6 303 6 644

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 4 477 5 653 4 366 3 930 3 921
Summe Eigenkapital 10 740 6 599 5 745 2 373 2 723
Summe Passiva 15 217 12 252 10 111 6 303 6 644

Adresse

5200 Illumina Way, 92122 San Diego
Telefon +1 (858) 202-4500
Fax +1 (858) 202-4545
Internet http://www.illumina.com

Management

Ankur Dhingra
Chief Financial Officer
Anna S. Richo
Independent Director
Caroline D. Dorsa
Independent Director
Conor McNamara
Vice President-Investor Relations
Eric Green
Chief Medical Officer
Frances Hamilton Arnold
Independent Director
Gary S. Guthart
Independent Director
Jacob Thaysen
Director, Chief Executive & Commercial Officer
Jakob Wedel
Chief Strategy & Corporate Development Officer
Keith Arlyn Meister
Independent Director
Kevin Pegels
Chief-Global Operations
Mark Field
Chief Information Officer
Pat Leckman
Chief People Officer
Philip W. Schiller
Independent Director
Robert S. Epstein
Independent Director
Scott B. Ullem
Independent Director
Scott Davies
Secretary, Chief Legal Officer & General Counsel
Scott Ericksen
Chief Accounting Officer & Vice President
Scott Gottlieb
Independent Chairman
Steven Barnard
Chief Technology Officer
Susan E. Siegel
Independent Director